Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MorphoSys
Pharma
Novartis to close 2 MorphoSys sites, lay off 330 staffers
In a move that’s becoming increasingly common in biopharma M&A, Novartis is shedding sites and staffers from the cancer firm it bought in February.
Fraiser Kansteiner
Dec 19, 2024 9:47am
PharmaEssentia nabs MorphoSys alum for CCO role
Dec 6, 2024 9:48am
2024's top biopharma M&A deals
Brought to you by
Pfizer
Incyte eyes label expansion for Monjuvi after phase 3 win
Aug 16, 2024 11:23am
Incyte picks up full Monjuvi rights from MorphoSys for $25M
Feb 6, 2024 9:59am
Novartis eyes MorphoSys buyout: Reuters
Feb 5, 2024 3:39pm
